Research in Rheumatology

The Role of Intervertebral Disc Cartilage Fragments in Modic Changes

Inflammation of the vertebral endplate and bone marrow are often seen in patients with chronic low back pain on MRIs. These changes are known as Modic type 1 changes (MC1). They occur adjacent to a degenerated intervertebral disc. In most cases disc degeneration does not cause pain. In contrast, MC1 are a source of pain in most cases. 

The aim of this study is to identify molecules that are overrepresented in MC1 and cause inflammation, and to find ways of inhibiting this process. From low back pain patients with MC1 who underwent lumbar spinal fusion at the Balgrist University Hospital we collected and analyzed the intervertebral disc tissue that was excised during this procedure. We found that molecular fragments of intervertebral disc cartilage proteins are much more abundant in MC1 tissue. We demonstrated that some of these fragments can cause infl ammation and degenerative changes in the intervertebral disc cartilage, which is typical for MC1. We also identifi ed the molecular mechanisms that generate these protein fragments and cause inflammation. Importantly, we successfully showed that blocking these mechanisms prevents infl ammation and degenerative changes.

Die Bandscheibe bei Modic Changes

Entzündungen der Wirbelendplatte und des Knochenmarks, bekannt als Modic Typ 1 Changes (MC1), werden oft bei chronischen Rückenschmerzen beobachtet und treten angrenzend an eine degenerierte Bandscheibe auf. Ziel der Studie ist es, zu untersuchen, wie die Bandscheibe MC1 verursacht und dieser Prozess blockiert werden kann. Dazu analysierte die Universitätsklinik Balgrist Bandscheibengewebe aus Eingriff en an Patientinnen und Patienten mit Rückenschmerzen und MC1. Wir fanden heraus, dass bei MC1-Betroffenen vermehrt entzündliche Abbauprodukte in den Bandscheiben vorkommen. Zusätzlich konnten wir deren molekulare Mechanismen identifizieren sowie aufzeigen, dass die Blockierung dieses Abbaumechanismus Entzündungen unterdrückt und degenerative Veränderungen verhindert.

At a Glance

Modic Changes

Key Collaborators
Project lead: PD Dr. Stefan Dudli
Prof. Dr. med. Florian Brunner
Prof. Dr. med. Mazda Farshad, MPH
Prof. Dr. med. Oliver Distler

Departments and Partners
Balgrist University Hospital:
Dept. of Physical Medicine and Rheumatology 
Dept. of Orthopedics

University Hospital Zurich
Balgrist Campus
University of Zurich

Clinical Relevance
Identification of molecular target for novel treatments for Modic Changes

Further Information 
> Foundation for Research in Rheumatology (FOREUM)